MAYA HARDMAN, PHC, PHARMD, BC-ADM
Pharmacist in SANTA FE, New Mexico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MAYA HARDMAN, PHC, PHARMD, BC-ADM filed 3,819 Medicare Part D claims in 2023 as a Pharmacist in SANTA FE, New Mexico, prescribing 37% generic.
- 4K
- Part D claims, 2023
- 37%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MAYA HARDMAN, PHC, PHARMD, BC-ADM's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
3,819 Top 9% higher than 91% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MAYA HARDMAN, PHC, PHARMD, BC-ADM?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New Mexico
How Pharmacist compares to other specialties among New Mexico providers
Pharmacist share within New Mexico
Pharmacist is one of the more visible NUCC categories in New Mexico
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pharmacist ABMS/AOA estimate
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pharmacist US NPIs
Specialty board-certified rate — Pharmacist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MAYA HARDMAN, PHC, PHARMD, BC-ADM appears in the CMS NPPES registry as a Pharmacist provider holding PHC, PHARMD, BC-ADM credentials at 1035 ALTO ST, SANTA FE, NM, 87501, with a listed phone of (505) 982-4425. NPI 1386261683 was issued on 07/02/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HARDMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,819 prescription claims written by this provider, covering 221 Medicare beneficiaries and totaling roughly $2.3 million in drug spend, split 63% brand-name and 37% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1386261683 |
|---|---|
| Specialty | Pharmacist |
| Credentials | PHC, PHARMD, BC-ADM |
| Gender | Female |
| NPI Issued | 07/02/2020 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MAYA HARDMAN, PHC, PHARMD, BC-ADM's current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
Brand vs generic prescribing mix · Brand-heavy
63% brand-name claims vs 37% generic, on 3,819 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,455
- Total Day Supply
- 157,133
- Brand vs Generic
- 63% brand / 37% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $16K
Patient Demographics
- Average Patient Age
- 69.1 years
- Avg HCC Risk Score
- 1.43
- Gender Split
- 54% female / 46% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MAYA HARDMAN, PHC, PHARMD, BC-ADM prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trulicity
Trulicity
575 claims
- Ozempic
Ozempic
342 claims
- Metformin Hcl Er
Metformin Hcl Er
332 claims
- Mounjaro 198
Mounjaro
198 claims
- Rosuvastatin Calcium 157
Rosuvastatin Calcium
157 claims
- Xigduo Xr 149
Xigduo Xr
149 claims
- Lisinopril 143
Lisinopril
143 claims
- Synjardy Xr 120
Synjardy Xr
120 claims
| Drug | Claims |
|---|---|
| Trulicity Dulaglutide | 575 |
| Ozempic Semaglutide | 342 |
| Metformin Hcl Er Metformin Hcl | 332 |
| Mounjaro Tirzepatide | 198 |
| Rosuvastatin Calcium | 157 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 149 |
| Lisinopril | 143 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 120 |
| Farxiga Dapagliflozin Propanediol | 106 |
| Atorvastatin Calcium | 99 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How MAYA HARDMAN, PHC, PHARMD, BC-ADM fits within the Pharmacist landscape nationally.
MAYA HARDMAN, PHC, PHARMD, BC-ADM's 3,819 claims are above the specialty average of 135.
Nearby Pharmacist Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as HARDMAN.
Compare Pharmacist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Mexico
Frequently Asked Questions
What is MAYA HARDMAN, PHC, PHARMD, BC-ADM's specialty? ▼
How much does MAYA HARDMAN, PHC, PHARMD, BC-ADM prescribe under Medicare Part D? ▼
Where is MAYA HARDMAN, PHC, PHARMD, BC-ADM located? ▼
What is MAYA HARDMAN, PHC, PHARMD, BC-ADM's NPI number? ▼
Does MAYA HARDMAN, PHC, PHARMD, BC-ADM prescribe more brand-name or generic drugs? ▼
How many Pharmacist providers are there in the US? ▼
What drugs does MAYA HARDMAN, PHC, PHARMD, BC-ADM prescribe most often? ▼
Does MAYA HARDMAN, PHC, PHARMD, BC-ADM accept Medicare? ▼
How can I verify MAYA HARDMAN, PHC, PHARMD, BC-ADM's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology